South San Francisco, CA, April 29, 2025 – FlemingMartin is pleased to announce that Structure Therapeutics (Nasdaq: GPCR), a clinical-stage biopharma company dedicated to developing and delivering novel, oral therapeutics targeting chronic cardiovascular, metabolic, and pulmonary conditions like diabetes, obesity, NAFLD/NASH, pulmonary hypertension, and pulmonary fibrosis, has hired Trent Hamilton as Vice President, Global Talent.
Trent possesses 20+ years of Talent Acquisition, Talent Development, and broader Human Resources expertise from the biotechnology, pharmaceutical, technology, and aerospace industries. Trent has consistently earned promotions to roles of increasing scope and responsibility over his career with global organizations such as Gilead Sciences (Nasdaq: GILD), Amgen (Nasdaq: AMGN), Veritas (acquired by Cohesity), and Honeywell (Nasdaq: HON). Trent has also spent time in a pre-commercial biotech/biopharma setting, previously serving as VP Talent Acquisition and Management at Atara Therapeutics (Nasdaq: ATRA).
Trent earned his MBA in Organizational Behavior and Human Resources along with his bachelor’s degree in Human Development and Family Studies from Brigham Young University.
